Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia

BACKGROUND: Levodopa‐carbidopa intestinal gel (LCIG) treatment has shown variable effect on dyskinesia in Parkinson's disease (PD). OBJECTIVE: To identify PD patients who are likely to have troublesome dyskinesia under LCIG treatment and describe the pharmacokinetic‐dynamic profile and dyskines...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mov Disord Clin Pract
Main Authors: Fabbri, Margherita, Zibetti, Maurizio, Calandra‐Buonaura, Giovanna, Contin, Manuela, Sambati, Luisa, Mohamed, Susan, Romagnolo, Alberto, Berchialla, Paola, Imbalzano, Gabriele, Giannini, Giulia, Rizzone, Mario G., Artusi, Carlo Alberto, Cortelli, Pietro, Lopiano, Leonardo
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Inc. 2020
主題:
Research Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604637/
https://ncbi.nlm.nih.gov/pubmed/33163564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.13068
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍